PRENWNasdaqPharmaceutical PreparationsUS GAAP · USD

Prenetics Global Ltd

Prenetics Global Ltd is a U.S.-listed health sciences company focused on consumer health, wellness, and longevity products through its IM8 brand and the CircleDNA testing business. The company operates across direct-to-consumer channels and related digital commerce platforms, with product and customer activity extending across multiple markets.

Ask about the company
Revenue30.6m USD
+40.8 %y/y
Operating profit (EBIT)-57.5m USD
−1.7 %y/y
EBIT margin-187.8%
+72.3 ppy/y
Net income-46.3m USD
+26.2 %y/y
Free cash flow-29.9m USD
−104.0 %y/y

Fiscal year 2024 · change from previous year

Development 2021–2024

-300-200-1000100m USD2021: 13 m USD2021: EBIT -217 m USD20212022: 13 m USD2022: EBIT -226 m USD20222023: 22 m USD2023: EBIT -57 m USD20232024: 31 m USD2024: EBIT -57 m USD2024TTM 2025: 69 m USDTTM 2025: EBIT -54 m USDTTM69-54
RevenueOperating profit (EBIT)TTM = last 12 months, not a full fiscal year
Ask Clarifo about Prenetics Global Ltd

Business

Share of revenue
IM8 health and longevity products97 %

Premium consumer health and longevity offerings sold under the IM8 brand.

CircleDNA genetic testing3 %

Consumer DNA testing products and related health insights services.

Customers

Prenetics sells primarily to consumers who purchase health, wellness, and longevity products directly online. It also serves individuals seeking genetic testing and personalized health information through CircleDNA. Brand-led social commerce and digital acquisition are central to how customers discover and buy the products.

Premium wellness consumers

Buy IM8 products for health, longevity, and lifestyle positioning.

Direct-to-consumer digital shoppers

Discover and purchase through TikTok, Meta, and brand websites.

Genetic testing customers

Buy CircleDNA kits and reports for personal health insights.

Strategy

Prenetics' strategy centers on scaling IM8 through data-driven direct-to-consumer acquisition, especially social commerce and paid digital channels. The company also emphasizes preserving capital for product innovation, clinical research, and selective opportunities while using cohort-based financing to support customer acquisition. Governance and board expertise are being aligned with consumer brand growth and digital performance marketing.

Scale IM8 customer acquisitionShort term

The business depends on efficient direct-to-consumer demand generation.

Improve cohort economicsShort term

Better cohort quality supports repeat purchases and funded growth.

Maintain capital flexibilityMedium term

The company wants to fund growth without overusing equity capital.

Geography

Prenetics operates as a cross-border consumer health business with sales driven through digital channels rather than a single manufacturing geography. The available reports indicate broad international customer reach, including testing across dozens of markets, while the company remains U.S.-listed and reports in U.S. dollars. Geography matters because customer acquisition efficiency, shipping, regulation, and consumer preference can differ significantly by market.

Risks

The main business risk is that Prenetics' growth depends on digital customer acquisition economics, which can deteriorate if advertising costs rise or conversion rates weaken. Consumer health and wellness brands also face competition, product efficacy scrutiny, and regulatory risk across multiple markets. Accounting and financing structures tied to future customer revenue add complexity to reported results and investor analysis.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Customer acquisition efficiency risk1Consumer demand concentration2Regulatory and claims risk3International execution risk4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Customer acquisition efficiency riskImpact: HighLikelihood: High

    The model relies on paid digital channels and cohort economics.

    Exposure: IM8 and other DTC brands

  2. Consumer demand concentrationImpact: HighLikelihood: Medium

    A large share of value depends on a small number of consumer brands.

    Exposure: IM8

  3. Regulatory and claims riskImpact: HighLikelihood: Medium

    Health, wellness, and genetic testing products can face oversight over claims and marketing.

    Exposure: Supplements and DNA testing

  4. International execution riskImpact: MediumLikelihood: Medium

    Selling across many markets adds logistics, localization, and compliance complexity.

    Exposure: 43-market testing and global DTC sales

Ask Clarifo about Prenetics Global Ltd

Accounting

Judgemental items
Customer value fund accounting

The arrangement is treated as a liability and not operating revenue.

Impact: Affects balance sheet classification and interest expense

Fair value measurements

Current financial assets are measured at fair value through profit or loss.

Impact: Can create non-cash gains and losses in reported earnings

Revenue recognition timing

Consumer sales and cohort-based growth can create timing effects by quarter.

Impact: Impacts comparability across periods

Inventory accounting

Product businesses must value stock and launch inventory carefully.

Impact: Can affect gross profit and working capital

Similar listed companies

Publicly listed companies with a comparable business focus.

Crinetics Pharmaceuticals, Inc.

Pharmaceutical Preparations

Xenetic Biosciences, Inc.

XBIO · Pharmaceutical Preparations

ProtoKinetix, Inc.

PKTX · Pharmaceutical Preparations

Biomerica, Inc

BMRA · In Vitro & In Vivo Diagnostic Substances

Neuronetics, Inc.

STIM · Surgical & Medical Instruments & Apparatus

Bioregenx, Inc.

BRGX · Services-Computer Programming, Data Processing, Etc.

Last updated: 28/09/2026

Prenetics Global Ltd (PRENW) Revenue, Earnings & Financials 2024 – Clarifo